# FDA Inspection 1234208 - OneBlood, Inc. - March 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/85591774-4bcf-4bb3-a8f4-927e32379ecd
Source feed: FDA_Inspections

> FDA inspection 1234208 of OneBlood, Inc., March 12, 2024. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1234208
- Company Name: OneBlood, Inc.
- Inspection Date: 2024-03-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1085562 - 2019-04-08](https://www.keypedia.com/records/fda_inspections/oneblood-inc/651a651b-67c5-4b38-86c8-9764e9e7a058)
- FDA Inspection 971831 - 2016-03-23
- FDA Inspection 890524 - 2014-08-06
- FDA Inspection 771878 - 2012-03-01
- FDA Inspection 661908 - 2010-05-13

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/barbara-t-carmichael/4c451805-e327-450d-b2e5-48a40f6232fe)

Company: https://www.keypedia.com/companies/oneblood-inc/03b82d46-0d01-4074-866d-4f5f4233f8b2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d